Robert Forrester

Robert Forrester is currently a board member at Deciduous Therapeutics. Prior to this, they were the President, Chief Executive Officer, and Director at Verastem Oncology from January 2011 to June 2019. At Verastem, they were responsible for the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Robert then went on to be the Co-Founder and Director at Sevenoaks Biosystems from January 2014 to December 2016. After that, they became the Director at Gelesis from January 2015 to December 2018. Most recently, they have taken on the role of Board Member at Deciduous Therapeutics. Throughout their career, Forrester has shown a dedication to developing new therapies to improve the lives of those battling cancer.

Robert Forrester's educational career includes a bachelor's degree from the University of Bristol and a degree from the University of Law Guildford in the UK. Robert also has a certificate from the London Business School.